Open AccessAn introduction to pharmacovigilance: what a cardiologist must know
Author(s) -
Sumit Munjal
Publication year - 2016
Publication title -
journal of clinical and preventive cardiology
Language(s) - English
Resource type - Journals
eISSN - 2456-3366
pISSN - 2250-3528
DOI - 10.4103/2250-3528.192698
Subject(s) - pharmacovigilance , medicine , work (physics) , health professionals , process (computing) , health care , alternative medicine , medical emergency , medical education , business , drug , intensive care medicine , pharmacology , computer science , engineering , political science , pathology , mechanical engineering , law , operating system
The science of pharmacovigilance (PV) is important to ensure safety of patients and healthy volunteers taking medicinal products. A number of stakeholders are involved who contribute to the success of this field of medicine. One such contributor is physicians and health-care professionals who work in different therapeutic areas such as cardiology. As the understanding of this science evolves, the role of cardiologist becomes even more vital. The process of developing drugs is getting more complex, time consuming, and costly. However, several efficiencies can be achieved around accelerated drug development, cost effectiveness, risk management, managing health authority expectations, and developing personalized medicines. This is possible by increased collaboration between cardiologists and pharmaceutical medicine professionals. Therefore, it is important for a cardiologist to understand the basics of the science of PV and contribute further bringing new safe medicines to patients